Hyperphosphatemia

Hyperphosphatemia is related to tumoral calcinosis, hyperphosphatemic, familial, 1 and pseudohypoparathyroidism, type ib. An important gene associated with Hyperphosphatemia is FGF23 (Fibroblast Growth Factor 23), and among its related pathways/superpathways are Signaling by Receptor Tyrosine Kinases and Negative regulation of FGFR3 signaling. The drugs Calcium acetate and Calcium carbonate have been mentioned in the context of this disorder. Affiliated tissues include kidney and bone, and related phenotypes are homeostasis/metabolism and growth/size/body region